Laxativr Drug Card PDF

Preview

Summary

Drug Card for test review...

Description

Classification: Laxative Generic Name: Docusate Sodium Expected Pharmacological Action (Pharmacology): Stool softener that reduces surface tension of interfacing liquid contents of the bowel. This detergent activity promotes incorporation of additional liquid into stools, thus forming a softer mass. Usual Dose: Capsules: 50 mg; 100 mg; 250 mg Oral liquid: 150 mg/15 mL Oral solution: 10 mg/mL; 50 mg/mL Rectal suspension: 100 mg/5 mL; 283 mg/4 mL Syrup: 20 mg/5 mL; 50 mg/15 mL; 60 mg/15 mL Tablets: 100 mg Usual routes: PO, PR Therapeutic Uses: Constipation Expected Common Adverse Effects: throat irritation (oral). GI: bitter taste, mild abdominal cramping, Adverse Effects Requiring Nursing Action: . If constipation returns, check with a doctor or health care professional. Stop using this medicine and contact doctor or health care professional if experiencing any rectal bleeding or do not have a bowel movement after use. These could be signs of a more serious condition. Action: Prevention/Assessment/Intervention: Before giving drug, determine whether patient has adequate fluid intake, exercise, and diet. Drug is laxative of choice for patients who shouldn’t strain during defecation, including patients recovering from MI or rectal surgery, those with rectal or anal disease that makes passage of firm stools difficult, and those with postpartum constipation. Look alike-sound alike: Don’t confuse Colace with Cozaar. Likely Medication/Food Interactions: Mineral oil: May increase mineral oil absorption and cause toxicity and lipid pneumonia. Separate doses. Administration/Interventions/Evaluation of Effectiveness/Laboratory Work: - Constipation has gone. - Pt has easy stool passings. Patient Education: What will the safe nurse teach the client to DO or expect or report: Teach patient about dietary sources of fiber, including bran and other cereals, fresh fruit, and vegetables.

Instruct patient to use drug only occasionally and not for longer than 1 week without prescriber’s knowledge. Tell patient to stop drug and notify prescriber if severe cramping occurs. Advise patient not to use OTC formulations for more than 7 days or when abdominal pain, nausea, or vomiting is present....